Speeding Up Innovation to Tackle Diabetes
Diabetes affects more than 400 million people globally, and the number of cases is rising. There are insulin products that are both secure and efficient. But according to the International Diabetes Federation, many individuals who need insulin—tens of thousands of those with type 1 diabetes (T1D) and more than 30 million with type 2 diabetes (T2D)—do not have access to a steady supply at a reasonable price.
For vulnerable groups living in low- and middle-income nations, the situation is particularly bad. Healthcare systems are frequently not set up to assist the management of this chronic condition in these populations, therefore patients and their families must typically foot the bill out of pocket. Since 2008, diabetes has been included in the Access to Medicine Index due to the disease's substantial burden.
The World Health Organization is leading a new global initiative to guarantee that all individuals with diabetes have access to high-quality care and treatment that is equitable, thorough, and inexpensive through its 2021 Global Diabetes Compact. According to the Compact, one of the most essential areas of effort is to improve access to diagnostic equipment and medications, notably insulin, in low- and middle-income nations. The Compact will establish worldwide coverage targets for diabetes treatment. The network of public- and private-sector stakeholders required to deliver a full package of solutions includes the pharmaceutical corporations that manufacture and supply insulin.
With a greater emphasis on diabetes care, companies are developing new solutions for better managing diabetes and encouraging lifestyle changes. Insulin pumps, where some insulin pumps administer the medication continually, while others only do so during meals or substantial snacks, continuous glucose monitors where checking your blood sugar before and after meals, and understand how your diet, activity, and lifestyle affect your blood sugar levels become much easier, to insulin innovations which involve rapid-acting, long-lasting, and premixed formulas that can be delivered via many methods, such as syringes, pumps, and pens; there are multiple options for individuals as per their needs today.
In the following edition of Insights Care, “10 Most Trusted Diabetes Solution Providers in 2022,” we highlight ten such companies that have put forth their innovative foot in not only tackling the existing health concerns associated with diabetes, but also easing the lives of patients, and encourage new lifestyle and healthy habits. These companies have undergone intensive research and development in meeting the objective of a healthy life and attaining the trust of their customers which has brought us new hope for a diabetes-free world altogether.
